[In-hospital and ambulatory drug therapy of phlebologic diseases].
D000553:Ambulatory Care; D001581:Benzothiadiazines; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D004487:Edema / Q000188:drug therapy; D006569:Hesperidin / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D009318:Natriuresis / Q000187:drug effects; D011188:Potassium / Q000097:blood; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013831:Thiamine / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000188:drug therapy*; D014223:Triamterene / Q000627:therapeutic use; D014648:Varicose Veins / Q000188:drug therapy*; D014689:Venous Insufficiency / Q000188:drug therapy*
D001581:Benzothiadiazines; D004232:Diuretics; D004338:Drug Combinations; D049993:Sodium Chloride Symporter Inhibitors; D006569:Hesperidin; D011188:Potassium; D014223:Triamterene; D013831:Thiamine
Stationäre und ambulante medikamentöse Therapie phlebologischer Erkrankungen